Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784849 · ClinicalTrials.gov registry record · Phase 2
Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
A Phase 2 study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT00784849 is a Phase 2 study that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 62 participants.
The verdict
NCT00784849, a Phase 2 study, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to develope a one-step procedure to perform a biopsy of axillary lymph nodes on the same side as the breast tumor in women diagnosed with breast cancer.
Interventions
- DRUG Methylene blue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2004-11 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00784849
The ClinicalTrials.gov registry entry for NCT00784849 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methylene blue is the first listed.
NCT00784849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00784849 about?
NCT00784849 is a clinical study titled "Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)". The purpose of this study is to develope a one-step procedure to perform a biopsy of axillary lymph nodes on the same side as the breast tumor in women diagnosed with breast cancer.
What is the current status of trial NCT00784849?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2004-11. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00784849?
The interventions under investigation include: Methylene blue (DRUG).
Who is sponsoring clinical trial NCT00784849?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.